![]()
|
|
||||||||
J Biol Chem, Vol. 273, Issue 27, 16647-16650, July 3, 1998
,
,
,
,
From the ¶ Cancer Pharmacology, Dana-Farber Cancer
Institute, Harvard Medical School, Boston, Massachusetts 02115, the
Acquired multidrug resistance to anti-cancer
agents has been associated with overexpression of the P-glycoprotein
and other members of the ATP-binding cassette superfamily. The present
studies demonstrate that SCC-25 cells selected for resistance to the
alkylating agent cisplatin (CDDP) overexpress the anti-apoptotic
Bcl-xL protein. In contrast to parental cells, the
SCC-25/CDDP-resistant variant failed to exhibit activation of
caspase-3, cleavage of protein kinase C
Department of Otolaryngology, The Jikei University School
of Medicine, Tokyo 105, Japan, the
Department of Microbiology
and Immunology, Kimmel Cancer Institute, Philadelphia, Pennsylvania
19107, and the ** Lilly Research Laboratories, Lilly Corporate Center,
Indianapolis, Indiana 46285
, and other characteristics
of apoptosis in response to CDDP. Similar results were obtained when
SCC-25/CDDP cells were exposed to the structurally and functionally
unrelated antimetabolite 1-
-D-arabinofuranosyl-cytosine
(ara-C). Other cells selected for resistance to doxorubicin or
vincristine also exhibited overexpression of Bcl-xL and
failed to respond to CDDP and ara-C with activation of caspase-3. The
results further demonstrate that multidrug-resistant cells exhibit a
block in the release of mitochondrial cytochrome c into the
cytosol and that this effect is dependent on overexpression of
Bcl-xL. The demonstration that lysates from the resistant
cells respond to the addition of cytochrome c with
activation of caspase-3 confirms that the block in apoptosis is because
of inhibition of mitochondrial cytochrome c release. These
findings demonstrate that cells respond to diverse classes of
anti-cancer drugs with overexpression of Bcl-xL and that
this response represents another mechanism of acquired multidrug
resistance.
This article has been cited by other articles:
![]() |
O. Fantappie, M. Solazzo, N. Lasagna, F. Platini, L. Tessitore, and R. Mazzanti P-Glycoprotein Mediates Celecoxib-Induced Apoptosis in Multiple Drug-Resistant Cell Lines Cancer Res., May 15, 2007; 67(10): 4915 - 4923. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Raina, S. Kharbanda, and D. Kufe The MUC1 Oncoprotein Activates the Anti-apoptotic Phosphoinositide 3-Kinase/Akt and Bcl-xL Pathways in Rat 3Y1 Fibroblasts J. Biol. Chem., May 14, 2004; 279(20): 20607 - 20612. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Holleman, M. L. d. Boer, K. M. Kazemier, G. E. Janka-Schaub, and R. Pieters Resistance to different classes of drugs is associated with impaired apoptosis in childhood acute lymphoblastic leukemia Blood, December 15, 2003; 102(13): 4541 - 4546. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. RAIT, K. F. PIROLLO, D. ULICK, K. CULLEN, and E. H. CHANG HER-2-Targeted Antisense Oligonucleotide Results in Sensitization of Head and Neck Cancer Cells to Chemotherapeutic Agents Ann. N.Y. Acad. Sci., December 1, 2003; 1002(1): 78 - 89. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Vasilevskaya, T. V. Rakitina, and P. J. O'Dwyer Geldanamycin and its 17-Allylamino-17-Demethoxy Analogue Antagonize the Action of Cisplatin in Human Colon Adenocarcinoma Cells: Differential Caspase Activation as a Basis for Interaction Cancer Res., June 15, 2003; 63(12): 3241 - 3246. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Nowak Protein Kinase C-alpha and ERK1/2 Mediate Mitochondrial Dysfunction, Decreases in Active Na+ Transport, and Cisplatin-induced Apoptosis in Renal Cells J. Biol. Chem., November 1, 2002; 277(45): 43377 - 43388. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M. Gonzalez, M. A. Fuertes, C. Alonso, and J. M. Perez Is Cisplatin-Induced Cell Death Always Produced by Apoptosis? Mol. Pharmacol., April 1, 2001; 59(4): 657 - 663. [Full Text] |
||||
![]() |
X. Li, M. Marani, R. Mannucci, B. Kinsey, F. Andriani, I. Nicoletti, L. Denner, and M. Marcelli Overexpression of BCL-XL Underlies the Molecular Basis for Resistance to Staurosporine-induced Apoptosis in PC-3 Cells Cancer Res., February 1, 2001; 61(4): 1699 - 1706. [Abstract] [Full Text] |
||||
![]() |
X.-H. Yang, T. L. Sladek, X. Liu, B. R. Butler, C. J. Froelich, and A. D. Thor Reconstitution of Caspase 3 Sensitizes MCF-7 Breast Cancer Cells to Doxorubicin- and Etoposide-induced Apoptosis Cancer Res., January 1, 2001; 61(1): 348 - 354. [Abstract] [Full Text] |
||||
![]() |
U. Zangemeister-Wittke, S. H. Leech, R. A. Olie, A. P. Simões-Wüst, O. Gautschi, G. H. Luedke, F. Natt, R. Häner, P. Martin, J. Hall, et al. A Novel Bispecific Antisense Oligonucleotide Inhibiting Both bcl-2 and bcl-xL Expression Efficiently Induces Apoptosis in Tumor Cells Clin. Cancer Res., June 1, 2000; 6(6): 2547 - 2555. [Abstract] [Full Text] |
||||
![]() |
H. Kojima, H. Miyazaki, Y. Tanaka, M. Shiwa, T. Koga, and H. Moriyama Role of Bcl-xL Protein in Differentiation and Apoptosis of Human Middle Ear Cholesteatoma Epithelium Arch Otolaryngol Head Neck Surg, July 1, 1999; 125(7): 738 - 742. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wartenberg, F. C. Ling, M. Schallenberg, A. T. Baumer, K. Petrat, J. Hescheler, and H. Sauer Down-regulation of Intrinsic P-glycoprotein Expression in Multicellular Prostate Tumor Spheroids by Reactive Oxygen Species J. Biol. Chem., May 11, 2001; 276(20): 17420 - 17428. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Datta, E. Oki, K. Endo, V. Biedermann, J. Ren, and D. Kufe XIAP Regulates DNA Damage-induced Apoptosis Downstream of Caspase-9 Cleavage J. Biol. Chem., October 6, 2000; 275(41): 31733 - 31738. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |